Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Setiawati E"'
Publikováno v:
Clinical Pharmacology: Advances and Applications, Vol Volume 10, Pp 43-51 (2018)
Raymond R Tjandrawinata,1 Arini Setiawati,2 Dwi Nofiarny,1 Liana W Susanto,1 Effi Setiawati3 1Dexa Laboratories of Biomolecular Sciences Unit, Dexa Medica Group, Cikarang, West Java, Indonesia; 2Department of Pharmacology and Therapeutics, Medical Fa
Externí odkaz:
https://doaj.org/article/ffa0af854e66411f82e0a722b4e6620e
Publikováno v:
Clinical Pharmacology: Advances and Applications, Vol 2015, Iss default, Pp 69-75 (2015)
Raymond R Tjandrawinata,1 Effi Setiawati,2 Ratih Sofia Ika Putri,2 Vincent Angga Gunawan,2 Fenny Ong,1 Liana W Susanto,1 Dwi Nofiarny11Dexa Laboratories of Biomolecular Sciences, Cikarang, West Java, Indonesia; 2PT Equilab International Bioavailabili
Externí odkaz:
https://doaj.org/article/0177166afbd64b0ebda8d85e6ab4ab99
Publikováno v:
Drug Design, Development and Therapy, Vol 2014, Iss default, Pp 1249-1255 (2014)
Raymond R Tjandrawinata,1 Effi Setiawati,2 Ratih Sofia Ika Putri,2 Danang Agung Yunaidi,2 Fawzia Amalia,2 Liana W Susanto1 1Dexa Laboratories of Biomolecular Sciences, Cikarang, Indonesia; 2PT Equilab International, Bioavailability and Bioequivalence
Externí odkaz:
https://doaj.org/article/b3996f9c3c964ae39639e64ec6368b90
Publikováno v:
Drug Design, Development and Therapy, Vol 2013, Iss default, Pp 841-847 (2013)
Raymond R Tjandrawinata,1 Effi Setiawati,2 Danang Agung Yunaidi,2 Ronal Simanjuntak,2 Iwan Dwi Santoso,2 Liana W Susanto1 1Dexa Laboratories of Biomolecular Sciences (DLBS), Cikarang, Indonesia; 2Bioavailability and Bioequivalence Laboratory, PT Equi
Externí odkaz:
https://doaj.org/article/24b7fadb8f38410dba7494d54a92cf50
Publikováno v:
Drug Design, Development and Therapy, Vol 2012, Iss default, Pp 311-316 (2012)
Raymond R Tjandrawinata,1 Effi Setiawati,2 Danang Agung Yunaidi,2 Iwan Dwi Santoso,2 Arini Setiawati,3 Liana W Susanto11Dexa Laboratories of Biomolecular Sciences (DLBS), Cikarang, Indonesia; 2Bioavailability and Bioequivalence Laboratory, Equilab In
Externí odkaz:
https://doaj.org/article/6b442b5270664390a1a3d0497f58b437
Autor:
Setiawati E
Publikováno v:
Bioequivalence & Bioavailability International Journal. 6:1-7
Etoricoxib is an oral selective cyclo-oxygenase-2 (COX-2) inhibitor with anti-inflammatory and antirheumatic properties belonging to the group of NSAIDs. Study Objective: The objective of this study was to investigate the bioequivalence study of Etor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae4f3bbb0aba8072845c603135c107d4
https://doi.org/10.23880/beba-16000172
https://doi.org/10.23880/beba-16000172
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Setiawati E
Publikováno v:
Bioequivalence & Bioavailability International Journal. 6:1-6
Cefixime is a broad-spectrum oral antibiotic used for treating a wide variety of bacterial infections. Study Objective: The objective of this study was to find out whether bioequivalence study of Cefixime 200 mg, Profim® capsule manufactured by PT P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ae5033523039b538b7d7a161674aac9
https://doi.org/10.23880/beba-16000169
https://doi.org/10.23880/beba-16000169
Publikováno v:
Journal of the Indonesian Tropical Animal Agriculture. Dec2020, Vol. 45 Issue 4, p287-297. 11p.
Autor:
Syukriani, Yoni, Noviandhari, A., Arisanti, N., Setiawati, E. P., Rusmil, V. K., Dhamayanti, M., Sekarwana, N.
Additional file 1: Supplementary Table 1. Types of violence, timeframe, and offenders.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05fa80162aca4ed7d4436c0ab5d19502
